Embark Veterinary
Embark Dog DNA Test | Most Accurate Breed Identification | Highest Reviewed Online
- Business Model
- B2C
- Website
- embarkvet.com
- Last Round
- Series BJul 2021
- Rounds
- 4
About
Consumer dog DNA testing company providing breed identification, ancestry, and health screening.
Summary
Embark Veterinary is a Genomics company based in United States. Its most recent funding was a Series B round in Jul 2021. Investors include Slow Ventures, F-Prime Capital and SoftBank.
Tech & App Stack
9 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2021
Sign up to see all 4 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
.png)
